© 2001 by European Society of Cardiology
Copyright © 2001, European Society of Cardiology
Estrogen inhibits mechanical strain-induced mitogenesis in human vascular smooth muscle cells via down-regulation of Sp-1
aHormones and The Vasculature Laboratory, Baker Institute and Alfred Heart Centre, Alfred Hospital, Melbourne, Australia
bVascular Research Laboratory, Cardiology Division, University of California, San Francisco, CA, USA
cDivision of Nephrology, University of California, San Francisco, CA, USA
dBerlex Biosciences, Richmond, CA 94143, USA
* Corresponding address. Alfred and Baker Medical Unit, 3rd Floor, Alfred Hospital, Commercial Road, Prahran, VIC 3181, Australia. Tel.: +61-3-9276-3263; fax: +61-3-9276-2461 k.sudhir{at}alfred.org.au
Objective: The cellular basis of the cardioprotective effects of estrogen are largely unknown. An inhibitory effect on vascular smooth muscle (VSM) growth has been proposed. We examined the effect of 17β-estradiol (E2) on mechanical strain-induced mitogenesis in human fetal VSM cells. Methods and results: Cells were grown on fibronectin-coated plates with silicone-elastomer bottoms, and exposed to cyclic mechanical strain (60 cycles/min), with and without E2 (1 nmol/l), for 48 h. [3H]-Thymidine incorporation was measured during the last 6 h. Strain induced 1.5–2 fold increases in DNA synthesis that were attenuated by antibodies to platelet-derived growth factor (PDGF) AA and BB. Strain also induced increases both in mRNA and protein levels of Sp-1, a transcription factor that binds to the PDGF-A gene promoter site. E2 attenuated strain-induced mitogenesis, and also increases in mRNA and protein levels of Sp-1. The estrogen receptor (ER) antagonist ICI 182,780 (100 nmol/l) reversed the inhibitory effect of E2 on strain-induced increases in DNA synthesis and Sp-1 protein. RT-PCR analysis showed presence of both ER-
and -β in these cells. Conclusions: Estrogen inhibits strain-induced mitogenesis in human VSM cells via an ER mediated process involving down-regulation of the transcription factor Sp-1.
KEYWORDS Gender; Growth factors; Platelets; Smooth muscle